Circular Genomics Inc. retweeted
Exciting news from our funded investigators @CircGenomics! Our investment is advancing circRNA, a novel blood-based biomarker for diagnosing and predicting Alzheimer's progression, supported by Diagnostics Accelerators (DxA).
Circular Genomics has been awarded a $250K investment from the Alzheimer’s Drug Discovery Foundation to advance our circular RNA blood-based early detection diagnostic testing for Alzheimer’s Disease.
Read the full press release here: hubs.la/Q03wdq7H0
Circular Genomics Inc. retweeted
In this week's San Diego Newsletter: Adcentrx gets FDA Orphan Drug nod for gastric cancer drug; @CircGenomics snags $250K for Alzheimer’s RNA test; @iambic_ai + @Rev_Medicine launch partnership; @UCSDExtStudies offers Business of Biotech course. Subscribe: bit.ly/4iqn5b1
Circular Genomics Inc. retweeted
In this week's San Diego Newsletter: @CircGenomics joins Lilly Gateway Labs to advance its RNA platform for Alzheimer’s; @Dexcom survey shows providers prefer CGM tech over new diabetes meds; @ScrippsHealth plans $1.2B med center in San Marcos. Subscribe: bit.ly/4iqn5b1
Circular Genomics Inc. retweeted
Happy #NewMemberMonday!
👩🔬 @AscendisPharma leverages its technology to create therapies in endocrinology and oncology
🥼 @CircGenomics specializes in precision psychiatric and neurologic medicine
🧪 @Mesa_Labs manufactures life science tools and quality control products

ALT Happy #NewMemberMonday! 👩🔬 @AscendisPharma leverages its technology to create therapies in endocrinology and oncology 🥼 @CircGenomics specializes in precision psychiatric and neurologic medicine 🧪 @Mesa_Labs manufactures life science tools and quality control products ✨ #DecibelBio is revolutionizing plant biotechnology with the first crop epigenetic platform 🔬 @EurofinsCDMO Alphora provides clients with API and drug product development services 👨🔬 #SnowCanyonTherapeutics develops therapies for neurodegenerative diseases
Circular Genomics Inc. retweeted
#PaulSargeant, President & CEO of @CircGenomics, leads a trailblazing biotech firm leveraging circular RNA (circRNA) biomarkers to develop advanced diagnostics — transforming mental health and neurology with precision and innovation.
Read More: lnkd.in/d8R38R4H
Circular Genomics Inc. retweeted
Update
#genomics #antidepressants #biomarkers #diagnostics #psychiatry #precisionmedicine
Circular Genomics Unveils MindLight™: The First SSRI Antidepressant Response Test Based on Brain-Derived Biomarkers (nextedge.in)
Circular Genomics Inc. retweeted
Daily MedTech News with Smarteeva: 18th Sep
☑️ @CircGenomics launches a new SSRI antidepressant response test, utilizing circular RNA biomarkers to improve precision in psychiatry.
☑️ @AbbottGlobal partners with iCardio.ai to develop AI applications for electrophysiology imaging technologies.
☑️ @Philips introduces the FDA-approved 160 cm version of its LumiGuide endovascular navigation wire, enhancing procedural capabilities.
☑️ @bostonscientific expands the FDA label for Ingevity+ pacing leads, now including conduction system pacing (CSP) and left bundle branch area (LBBA) sensing for pacemakers.
☑️ @senseonics wins FDA approval for its 365-day implantable continuous glucose monitor (CGM), bringing the longest-lasting CGM to market.
#InsightswithSmarteeva #Medtech #complaintmanagement #Pharma #Smarteeva #biotech #medtechtrends #medtechindustry #medicaltechnology #technology #health #medicaldevicediagnostics #ai #mdr #recalls #complaints #mir #fda #cvr











